Real-world savings in medication-related costs up to 5 years with the use of the second-generation trabecular implant (iStent inject®) in mild open-angle glaucoma.

Saved in:

Bibliographic Details
Title:	Real-world savings in medication-related costs up to 5 years with the use of the second-generation trabecular implant (iStent inject®) in mild open-angle glaucoma.
Alternate Title:	Economia real em custos relacionados a medicamentos por até 5 anos com o uso do implante trabecular de segunda geração (iStent inject®) no glaucoma de ângulo aberto inicial.
Authors:	Paletta Guedes, Ricardo Augusto¹ palettaguedes@yahoo.com, Guedes Moraes, Daniel Augusto², Paletta Guedes, Vanessa Maria², Marcelo Gravina, Daniela², Chaoubah, Alfredo¹
Source:	Revista Brasileira de Oftalmologia. 2025, Vol. 84, p1-8. 8p.
Database:	Academic Search Ultimate

Description
ISSN:	00347280
DOI:	10.37039/1982.8551.20250072